Product NewsLife Sciences
Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing
The award comes after Avacta obtained regulatory approval for the Lateral Flow Test
News & Articles
Results per page
25
12 Articles Found | Selected Filters:
Product NewsLife Sciences
Avacta Demonstrates Key Performance Benefits of Affimer Technology for Affinity Separation
Affimer technology shown to offer key performance benefits compared to antibodies and other technologies in this application
Product NewsDrug discovery > Lead Discovery
Avacta Announces CAR-T Cell Therapy Research Collaboration with Major US Cancer Center
Affimer technology will potentially provide significant advantages over antibody fragment technology currently used in CAR-T cell modification
Industry NewsLife Sciences
Avacta and Leeds University Awarded £3.8m Medical Research Council Funding to Develop New Diagnostic Tests
Avacta collaborates to develop rapid tests to differentiate between viral and bacterial infections and to differentiate bacterial strains
